Qualified opioid treatment programs, practitioners and health centers can apply through June 4 for up to $200,000 a year for five years to expand access to Food and Drug Administration-approved opioid overdose treatments, the Substance Abuse and Mental Health Services Administration announced yesterday. SAMHSA expects to fund up to five recipients, who will partner with other prescribers in the community to develop best practices and train prescribers and individuals who support people at high risk for overdose. For more information, see the funding opportunity announcement.

Related News Articles

Headline
Continued rising drug prices, as well as shortages for many critical medications, are disrupting patient care and forcing hospitals to delay infrastructure and…
Headline
U.S. overdose death rates linked to synthetic opioids increased more than 45 percent in 2017, likely driven by illicitly manufactured fentanyl, according to a…
Headline
The Health Resources and Services Administration recently launched a program to provide eligible health care clinicians with student loan repayment assistance…
Insights and Analysis
Also in this weekly roundup of health care news: how mandated access to at-home palliative care has made all the difference for some patients; and a town’s…
Headline
Clinicians should strongly consider prescribing or co-prescribing naloxone to certain patients at risk for opioid overdose, and educating them about its use,…
Headline
The Food and Drug Administration yesterday approved a mobile medical application to help increase retention in outpatient treatment programs for opioid use…